Seres Therapeutics Archives -

The FDA has accepted for review Seres Therapeutics’ Biologics License Application (BLA) for SER-109, an investigational oral microbiome

FDA accepts review of SeresTx BLA for oral microbiome therapeutic

https://pharmaphorum.com/news/fda-accepts-review-of-serestx-bla-for-oral-microbiome-therapeutic/

Swiss food giant Nestle has firmed up its five-year-old alliance with US microbiome specialist Seres, paying $175 million

Nestle gets closer to Seres, pledging $525m for microbiome C. diff drug

https://pharmaphorum.com/news/nestle-gets-closer-to-seres-pledging-525m-for-microbiome-c-diff-drug/

AstraZeneca has announced an immuno-oncology collaboration with US biotech Seres Therapeutics, which will focus on increasing understanding of

AZ joins with Seres to research role of gut microbiome in cancer

https://pharmaphorum.com/news/az-joins-with-seres-to-research-role-of-gut-microbiome-in-cancer/

Seres Therapeutics